Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Future Oncology, Ahead of Print.


from Cancer via ola Kala on Inoreader http://ift.tt/2Bncn07
via IFTTT